Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunkyu Ko

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Oncotarget|October 20, 2018
Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashionGesa von Olshausen, Maria Quasdorff, Romina Bester, et al.
Gut|January 27, 2023
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cureLena Allweiss, Barbara Testoni, Mei Yu, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Development of sulfamoylbenzamide-based capsid assembly modulators for hepatitis B virus capsid assemblySyed Azeem Abbas, Hyeon-Min Cha, Sandesha Nayak, et al.
Journal of Hepatology|August 25, 2018
Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levelsChunkyu Ko, Anindita Chakraborty, Wen-Min Chou, et al.
Microbiology Spectrum|May 18, 2023
SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNASamuel Hofmann, Verena Plank, Peter Groitl, et al.
Nucleic Acids Research|December 20, 2021
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spreadShubhankar Ambike, Cho-Chin Cheng, Martin Feuerherd, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 25, 2024
Miniaturized Modular Click Chemistry-enabled Rapid Discovery of Unique SARS-CoV-2 M<sup>pro</sup> Inhibitors With Robust Potency and Drug-like ProfileMianling Yang, Myoung Kyu Lee, Shenghua Gao, et al.
Molecular Therapy. Nucleic Acids|August 13, 2025
MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccinationAnna D Kosinska, Martin Kächele, Helene A Kerth, et al.
Life Science Alliance|March 29, 2019
A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesisPeter Ac Wing, Tamara Davenne, Jochen Wettengel, et al.
Journal of Hepatology|June 25, 2021
T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in miceOliver Quitt, Shanshan Luo, Marten Meyer, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Oncotarget|October 20, 2018
Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashionGesa von Olshausen, Maria Quasdorff, Romina Bester, et al.
Gut|January 27, 2023
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cureLena Allweiss, Barbara Testoni, Mei Yu, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Development of sulfamoylbenzamide-based capsid assembly modulators for hepatitis B virus capsid assemblySyed Azeem Abbas, Hyeon-Min Cha, Sandesha Nayak, et al.
Journal of Hepatology|August 25, 2018
Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levelsChunkyu Ko, Anindita Chakraborty, Wen-Min Chou, et al.
Microbiology Spectrum|May 18, 2023
SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNASamuel Hofmann, Verena Plank, Peter Groitl, et al.
Nucleic Acids Research|December 20, 2021
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spreadShubhankar Ambike, Cho-Chin Cheng, Martin Feuerherd, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 25, 2024
Miniaturized Modular Click Chemistry-enabled Rapid Discovery of Unique SARS-CoV-2 M<sup>pro</sup> Inhibitors With Robust Potency and Drug-like ProfileMianling Yang, Myoung Kyu Lee, Shenghua Gao, et al.
Molecular Therapy. Nucleic Acids|August 13, 2025
MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccinationAnna D Kosinska, Martin Kächele, Helene A Kerth, et al.
Life Science Alliance|March 29, 2019
A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesisPeter Ac Wing, Tamara Davenne, Jochen Wettengel, et al.
Journal of Hepatology|June 25, 2021
T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in miceOliver Quitt, Shanshan Luo, Marten Meyer, et al.
Pageof 4